Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 29, 2014

View Archived Issues

The effect of bisphosphonate compounds in animal models of acute colitis

Recessive variant found in PCD deficiency with MODY-like diabetes

Invion updates on ongoing phase II trial of nadolol in mild asthma

Eutropics receives NCI contract to develop predictive tests for personalized AML treatment

Lipocine reports topline results from phase III trial of LPCN-1021

BerGenBio granted Wellcome Trust award for cancer development program

AstraZeneca discloses new FGFR-4 inhibitors

Reduced HYAL2 gene methylation in blood correlated with breast cancer

Safety and pharmacokinetics of ABT-767 in BRCA1 and BRCA2 germline tumors

FDA approves Vitekta

CHMP recommends approval of aclidinium bromide/formoterol fumarate

EMA recommends ketoconazole for approval in Cushing's syndrome

EMA committee recommends approval of Moventig

Roche divulges novel CB2 receptor agonists

Allergan discloses novel S1P1 receptor ligands

Roche discloses new agents for HCV infection

Genzyme presents promising data from 3-year follow up of CARE-MS I

New LRRK2 inhibitors disclosed by Merck & Co.

Application filed for marketing approval of remestemcel-L in Japan

Novartis applies for Japanese approval of panobinostat

EMA committee hands down positive opinion on Trulicity

FDA approves Iluvien for diabetic macular edema

Harvoni recommended for the treatment of chronic hepatitis C

EMA committee recommends European approval of Cyramza

Lixiana approved in Japan for additional indications

Signifor recommended by CHMP to treat patients with acromegaly

Boehringer Ingelheim's nintedanib receives positive opinion for second-line therapy of NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...